MicroRNA Expression in Barrett's Oesophagus
Author Information
Author(s): Haiart Sebastien, Watson David I, Leong Mary P, Astill David, Bright Tim, Hussey Damian J
Primary Institution: Flinders University, Flinders Medical Centre
Hypothesis
Two miRNAs with inflammatory and oncogenic roles, miR-101 and miR-196a, are differentially expressed in Barrett's oesophagus epithelium in patients with reflux treated medically vs. surgically.
Conclusion
The method of reflux treatment did not influence the expression of miR-101 and miR-196a in Barrett's oesophagus.
Supporting Evidence
- No significant differences in miR-101 and miR-196a expression in Barrett's oesophagus epithelium in patients treated by PPI vs. fundoplication.
- Secondary analysis showed a correlation between miR-196a expression and Barrett's oesophagus segment length.
Takeaway
Doctors looked at tiny pieces of tissue from patients with Barrett's oesophagus to see if two specific molecules were different based on how they treated their reflux, but they found no differences.
Methodology
Mucosal tissue was obtained at endoscopy from patients, RNA was extracted, and the expression of miR-101 and miR-196a was measured using real-time reverse transcription - polymerase chain reaction.
Potential Biases
Selection bias based on age may have influenced outcomes.
Limitations
There was a significant difference in age between the two reflux treatment groups, and no reference control tissues were included.
Participant Demographics
20 patients treated with PPI and 19 patients treated with fundoplication.
Statistical Information
P-Value
0.0039 for age difference, 0.014 for miR-196a correlation with Barrett's length
Confidence Interval
95% confidence intervals provided for various measurements.
Statistical Significance
p=0.768 and 0.211
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website